# Aceso Plasma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aceso-plasma

- Industry: Medical Devices & Equipment
- Headquarters: Virginia Beach, US
- Website: www.acesoplasma.com/
- Total disclosed funding: $0.5M
- Latest round: Series A (Jul 15, 2025)
- Investors on record: 1

## About

Aceso Plasma, based in the US, specializes in innovative air purification and decontamination technologies for military and healthcare sectors, enhancing safety through advanced plasma solutions.Aceso Plasma is focused on developing plasma-based technologies for disinfection and wound healing. The company is headquartered in Virginia Beach, US. In July 2025, Aceso Plasma raised USD 500,000 in Series A funding led by Stony Lonesome Group, marking a significant step in their growth strategy. The company was founded by individuals with a background in technology and healthcare, although specific details about the founders are not provided. Aceso Plasma’s recent funding will support the development of new plasma solutions for medical applications and has positioned the company for future growth.Aceso Plasma specializes in advanced air purification and decontamination technologies, primarily targeting military and healthcare applications. Their flagship products include a low-temperature, hand-portable plasma device that generates oxygen plasma for rapid disinfection and wound healing, as well as an air purification system designed to eliminate bacteria and viruses without the need for replaceable filters. These products cater to military personnel in the field, addressing chemical and biological hazards in environments where traditional cleaning methods are impractical. Aceso Plasma's technology is valuable not only for military units but also for healthcare providers and facilities seeking effective sterilization solutions in a range of settings. The company's offerings are marketed primarily in the United States, with potential applications in international defense and healthcare sectors.Aceso Plasma generates revenue through direct sales to military and healthcare organizations, focusing on high-value contracts for their specialized products. Transactions typically occur through B2B engagements, with clients ranging from military branches to healthcare facilities that require cutting-edge decontamination technology. The company’s pricing structure is tailored to institutional clients, emphasizing long-term partnerships and bulk purchase agreements to optimize value for both Aceso Plasma and its customers. Their products, particularly the hand-portable plasma device and air purification system, represent significant investments for clients seeking to enhance safety and operational efficiency in challenging environments. These strategic sales approaches enable Aceso Plasma to establish a robust client base while fostering trust and reliability within their target markets.In July 2025, Aceso Plasma raised USD 500,000 in Series A funding led by Stony Lonesome Group. The company will utilize this funding to further develop plasma-based solutions for wound care, hemorrhage control, and decontamination. Aceso Plasma plans to launch new products designed for medical applications, aiming to expand its market presence in both military and healthcare sectors. The company is also targeting additional geographic regions for market entry, although specific regions have not been disclosed. Through these initiatives, Aceso Plasma seeks to enhance its technological offerings and establish a broader client base.

## Funding rounds

- Series A, Jul 15, 2025, $0.5M — Stony Lonesome Group

## Investors

- Stony Lonesome Group (https://capitalatlas.ai/funds/stony-lonesome-group) — Series A